Detalhe da pesquisa
1.
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.
Am J Hum Genet
; 106(2): 264-271, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32004448
2.
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
N Engl J Med
; 376(6): 536-547, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28177873
3.
Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.
Blood
; 131(21): 2393-2398, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632022
4.
KIR Donor Selection: Feasibility in Identifying better Donors.
Biol Blood Marrow Transplant
; 25(1): e28-e32, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149149
5.
Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 25(4): 664-672, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537553
6.
Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 25(5): 949-954, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30594542
7.
Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia.
Biol Blood Marrow Transplant
; 24(10): 2003-2008, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879518
8.
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 24(4): 827-831, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155319
9.
High HLA-DP Expression and Graft-versus-Host Disease.
N Engl J Med
; 373(7): 599-609, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267621
10.
Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.
Biol Blood Marrow Transplant
; 23(7): 1054-1058, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389255
11.
Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.
Biol Blood Marrow Transplant
; 23(6): 1029-1037, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28263917
12.
Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
Biol Blood Marrow Transplant
; 23(1): 153-160, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746218
13.
Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
Biol Blood Marrow Transplant
; 22(12): 2276-2282, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641680
14.
Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.
Biol Blood Marrow Transplant
; 22(9): 1602-1607, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27220262
15.
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.
Blood
; 123(19): 3016-26, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652987
16.
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
Blood
; 123(8): 1270-8, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24408320
17.
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.
Blood
; 124(26): 3996-4003, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25323824
18.
Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
J Immunol
; 192(10): 4592-600, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748496
19.
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 21(9): 1589-96, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960307
20.
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
N Engl J Med
; 367(9): 805-16, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931314